anavar cycle

Rotigotine is neergolinovym agonist D1-3 dopamine receptors (ADRs), used to treat Parkinson’s anadrol cycle¬†disease. The therapeutic effect of rotigotine is caused by activation of D3, D2, and D1 receptors kaudato-putamenalnogo (basal ganglia – the caudate and putamen) brain complex. Rotigotine attenuates the severity of the clinical manifestations of idiopathic Parkinson’s disease (UPS). Clinical studies The […]